Literature DB >> 15716591

Alcohol intake modulates the genetic association between HDL cholesterol and the PPARgamma2 Pro12Ala polymorphism.

Stefan-Martin Brand-Herrmann1, Tatiana Kuznetsova, Andreas Wiechert, Katarzyna Stolarz, Valerie Tikhonoff, Klaus Schmidt-Petersen, Ralph Telgmann, Edoardo Casiglia, Ji-Guang Wang, Lutgarde Thijs, Jan A Staessen, Eva Brand.   

Abstract

The peroxisome proliferator-activated receptor gamma (PPARgamma) Pro12Ala polymorphism affects plasma lipids, but to what extent alcohol intake interferes with this association remains unknown. We randomly recruited 251 nuclear families (433 parents and 493 offspring) in the framework of the European Project on Genes in Hypertension study and genotyped 926 participants in whom all serum lipid variables and information on alcohol consumption were available for PPARgamma2 Pro12Ala. Genotype-phenotype relations were assessed using generalized estimating equations (GEE) and a quantitative transmission disequilibrium test (QTDT). The Ala12 allele was more frequent in Novosibirsk (0.17) than in Cracow (0.12) and Mirano (0.11) (P < 0.01). Using GEE (P = 0.03) or QTDT (P = 0.007), Italian offspring carrying the Ala12 allele had higher serum HDL cholesterol than noncarriers. HDL cholesterol levels were on average 0.086 mmol/l (P = 0.001) higher in drinkers than in nondrinkers. Compared with Pro12 homozygotes, Ala12 allele carriers consuming alcohol had higher serum total and HDL cholesterol, with the opposite trend occurring in nondrinkers. This genotype-alcohol interaction was independent of the type of alcoholic beverage and more pronounced in moderate than in heavy drinkers. We conclude that alcohol intake modulates the relation between the PPARgamma2 Pro12Ala and HDL cholesterol level and that, therefore, the Pro12Ala polymorphism, pending confirmation of our findings, might affect cardiovascular prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716591     DOI: 10.1194/jlr.M400405-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

Review 1.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

2.  Old-style epidemiology and epigeneticdemiology.

Authors:  Edoardo Casiglia; Valérie Tikhonoff
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

3.  Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: the CARDIA Study.

Authors:  Qi Wei; David R Jacobs; Pamela J Schreiner; David S Siscovick; Michael W Steffes; Myriam Fornage
Journal:  J Mol Med (Berl)       Date:  2006-09-06       Impact factor: 4.599

4.  A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol.

Authors:  Ida Surakka; Aaron Isaacs; Lennart C Karssen; Pirkka-Pekka P Laurila; Rita P S Middelberg; Emmi Tikkanen; Janina S Ried; Claudia Lamina; Massimo Mangino; Wilmar Igl; Jouke-Jan Hottenga; Vasiliki Lagou; Pim van der Harst; Irene Mateo Leach; Tõnu Esko; Zoltán Kutalik; Nicholas W Wainwright; Maksim V Struchalin; Antti-Pekka Sarin; Antti J Kangas; Jorma S Viikari; Markus Perola; Taina Rantanen; Ann-Kristin Petersen; Pasi Soininen; Asa Johansson; Nicole Soranzo; Andrew C Heath; Theodore Papamarkou; Inga Prokopenko; Anke Tönjes; Florian Kronenberg; Angela Döring; Fernando Rivadeneira; Grant W Montgomery; John B Whitfield; Mika Kähönen; Terho Lehtimäki; Nelson B Freimer; Gonneke Willemsen; Eco J C de Geus; Aarno Palotie; Manj S Sandhu; Dawn M Waterworth; Andres Metspalu; Michael Stumvoll; André G Uitterlinden; Antti Jula; Gerjan Navis; Cisca Wijmenga; Bruce H R Wolffenbuttel; Marja-Riitta Taskinen; Mika Ala-Korpela; Jaakko Kaprio; Kirsten O Kyvik; Dorret I Boomsma; Nancy L Pedersen; Ulf Gyllensten; James F Wilson; Igor Rudan; Harry Campbell; Peter P Pramstaller; Tim D Spector; Jacqueline C M Witteman; Johan G Eriksson; Veikko Salomaa; Ben A Oostra; Olli T Raitakari; H-Erich Wichmann; Christian Gieger; Marjo-Riitta Järvelin; Nicholas G Martin; Albert Hofman; Mark I McCarthy; Leena Peltonen; Cornelia M van Duijn; Yurii S Aulchenko; Samuli Ripatti
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

5.  The peroxisome proliferator-activated receptor delta +294T > C polymorphism and alcohol consumption on serum lipid levels.

Authors:  Xian-Liang Wei; Rui-Xing Yin; Lin Miao; Dong-Feng Wu
Journal:  Lipids Health Dis       Date:  2011-12-23       Impact factor: 3.876

6.  The role of metabolites under the influence of genes and lifestyles in bone density changes.

Authors:  Xuewei Lv; Yanfeng Jiang; Dantong Yang; Chengkai Zhu; Huangbo Yuan; Ziyu Yuan; Chen Suo; Xingdong Chen; Kelin Xu
Journal:  Front Nutr       Date:  2022-09-02

7.  PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.

Authors:  Ulla Vogel; Stine Segel; Claus Dethlefsen; Anne Tjønneland; Anne Thoustrup Saber; Håkan Wallin; Majken K Jensen; Erik B Schmidt; Paal Skytt Andersen; Kim Overvad
Journal:  BMC Med Genet       Date:  2009-06-07       Impact factor: 2.103

8.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

9.  PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population.

Authors:  Shu-Jun Gu; Zhi-Rong Guo; Zheng-Yuan Zhou; Xiao-Shu Hu; Ming Wu
Journal:  Lipids Health Dis       Date:  2014-01-26       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.